Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 10:31 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1057–1080 of 1,792 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Intervention 2 - Sham Treatment Clear all

Conditions: Peripheral Artery Disease, Peripheral Vascular Disease, Aging, Walking, Difficulty
Interventions: Far red light therapy, Sham light therapy; Device
Lead sponsor: Northwestern University; Other
Eligibility: 50 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Birmingham, Alabama • Chicago, Illinois

Conditions: Acute Myocardial Infarction, Congestive Heart Failure, ST-Elevation Myocardial Infarction
Interventions: IK-5001, Saline Solution; Device
Lead sponsor: Bellerophon BCM LLC; Industry
Eligibility: 18 Years and older
Enrollment: 303 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 16
States / cities: Birmingham, Alabama • Torrance, California • Washington D.C., District of Columbia + 13 more

Conditions: Degenerative Disc Disease
Interventions: Platelet-rich plasma (PRP), Platelet lysate (PL), and Platelet Poor Plasma (PPP), Sham procedure; Biological · Other
Lead sponsor: Regenexx, LLC; Industry
Eligibility: 25 Years to 65 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 2
States / cities: Broomfield, Colorado • Lone Tree, Colorado

Conditions: Schizophrenia
Interventions: Brain Fitness Program (BFP), Cognitive Package (Cogpack), Commercial Computer Games (Sporcle); Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 25 Years to 65 Years
Enrollment: 105 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 2
States / cities: Los Angeles, California • West Los Angeles, California

Conditions: Pediatric Burns
Interventions: magnesium sulfate, Normal Saline (0.9% NaCl); Drug
Lead sponsor: Hennepin Healthcare Research Institute; Other
Eligibility: 3 Years to 18 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2031
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Bipolar Disorder
Interventions: Omega-3 Supplementation, Psychoeducational Psychotherapy (PEP), Placebo; Drug · Behavioral · Other
Lead sponsor: L. Eugene Arnold; Other
Eligibility: 7 Years to 14 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Hypercholesterolemia
Interventions: ezetimibe, placebo; Drug
Lead sponsor: UCSF Benioff Children's Hospital Oakland; Other
Eligibility: 18 Years to 70 Years
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Berkeley, California

Conditions: Stress, Burnout, Professional, Stress, Job
Interventions: Herbaceous Essential Oil Blend, Citrus Essential Oil Blend, Inert Oil; Other
Lead sponsor: Nutraceuticals Research Institute; Other
Eligibility: 20 Years to 59 Years
Enrollment: 114 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Franklin, Tennessee

Conditions: Post Operative Urinary Retention
Interventions: Tamsulosin, Placebo; Drug
Lead sponsor: Jewish Hospital, Cincinnati, Ohio; Other
Eligibility: 18 Years and older
Enrollment: 170 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Spinal Cord Injuries
Interventions: Buspirone, Non-invasive Spinal Cord Stimulation, Overground stepping, Gravity Neutral Device, Body Weight Supported Treadmill Training, Rolling Walker; Drug · Device
Lead sponsor: University of Louisville; Other
Eligibility: 18 Years to 65 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2027
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Vaginal Dysbiosis, Vaginal Disease, Molecular-bacterial Vaginosis
Interventions: Probiotic Group, Placebo Group; Dietary Supplement
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 45 Years · Male only
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Social Anxiety Disorder
Interventions: D-Cycloserine, Placebo, Cognitive Behavioral Therapy; Drug · Behavioral
Lead sponsor: Jasper A. Smits; Other
Eligibility: 18 Years to 70 Years
Enrollment: 152 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2018
U.S. locations: 3
States / cities: Chicago, Illinois • Boston, Massachusetts • Austin, Texas

Conditions: Diagnostic, Procedures and Surgeries on or Through Accessible Mucous Membranes, of the Nasal Cavities
Interventions: Cocaine HCl 4% Topical Solution, Cocaine HCl 10% Topical Solution, Placebo Topical Solution; Drug
Lead sponsor: Lannett Company, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 159 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 2
States / cities: Bridgeport, Connecticut • Plano, Texas

Conditions: Stroke
Interventions: repetitive transcranial magnetic stimulation (rTMS), peripheral sensory stimulation; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2022
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Menopause, Estrogen Deficiency, Aging, Adiposity
Interventions: Degarelix, Transdermal Estradiol Patch, Transdermal Placebo Patch; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 20 Years to 45 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Pediatric Obesity
Interventions: Lifestyle intervention and carotenoid supplements, Lifestyle intervention and placebo; Other
Lead sponsor: Nemours Children's Clinic; Other
Eligibility: 8 Years to 11 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Peripheral Arterial Disease
Interventions: Carnosine; Drug
Lead sponsor: Shahid Baba; Other
Eligibility: 40 Years to 80 Years
Enrollment: 144 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 3
States / cities: Louisville, Kentucky

Conditions: Cutaneous Lichen Planus
Interventions: Placebo, GIA632; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 259 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 15
States / cities: Birmingham, Alabama • Fountain Valley, California • Miami, Florida + 12 more

Conditions: Menopause, Obesity, Abdominal, Aging, Weight Gain
Interventions: GnRH antagonist, Estrogen Product, Placebo estradiol, Placebo GnRH antagonist; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 40 Years to 65 Years · Female only
Enrollment: 57 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Atrial Fibrillation (AF)
Interventions: discontinue anticoagulation therapy, Anticoagulant drugs, Catheter Ablation; Behavioral · Drug · Procedure
Lead sponsor: China National Center for Cardiovascular Diseases; Government
Eligibility: 18 Years and older
Enrollment: 3,160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Left Ventricular Dysfunction
Interventions: Adult stem cells, Placebo; Biological
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 21 Years and older
Enrollment: 87 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 5
States / cities: Gainesville, Florida • Minneapolis, Minnesota • Cleveland, Ohio + 2 more

Conditions: Infant Development
Interventions: Docosahexaenoic acid (DHA) and arachidonic acid (ARA), Corn oil placebo; Dietary Supplement
Lead sponsor: Retina Foundation of the Southwest; Other
Eligibility: 351 Days to 379 Days
Enrollment: 116 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: HCC
Interventions: Sorafenib, VT-122 (propranolol plus etodolac), Placebo; Drug
Lead sponsor: Vicus Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2016
U.S. locations: 10
States / cities: Berkeley, California • Atlanta, Georgia • New Brunswick, New Jersey + 6 more

Conditions: Hernia Abdominal Wall, Botox Injection, Hernia Incisional Ventral, Hernia Repair With Compartment Syndrome, Hernia Surgery, Hernia, Hernia Incisional
Interventions: OnabotulinumtoxinA Injection, Saline (placebo) Injection, OnabotulinumtoxinA, 0.9 % Normal Saline, Open Ventral Hernia Repair; Procedure · Drug
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 188 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Cleveland, Ohio

Search by objective public record fields.

Far Red Light to Improve Functioning in PAD

IK-5001 for the Prevention of Remodeling of the Ventricle and Congestive Heart Failure After Acute Myocardial Infarction

Trial for Treating Painful Degenerative Disc Disease

Evaluating Two Types of Cognitive Training in Veterans With Schizophrenia

Magnesium Sulfate in Pediatric Burn Dressing Changes

Omega-3 and Therapy Study for Childhood Bipolar Disorder- Not Otherwise Specified

Effects of Ezetimibe on the Absorption of Oxidized Cholesterol

Aromatherapy for Stress and Burnout Among Healthcare Providers

Tamsulosin to Prevent Postoperative Urinary Retention in Laparoscopic Inguinal Hernia Repair

Transformation of Paralysis to Stepping

Feasibility of an Oral Intervention for Sexual Health in Transgender Men

Dose Timing of D-Cycloserine to Augment CBT for Social Anxiety Disorder

Topical Application of Cocaine HCl 4% and 10% on Safety and Efficacy in Local (Topical) Anesthesia

Can rTMS Enhance Somatosensory Recovery After Stroke?

Cardiometabolic Consequences of the Loss of Ovarian Function

Family-based Lifestyle Intervention Program and Carotenoid Supplementation for Children With Obesity

Effects of Carnosine In Patients With Peripheral Arterial Disease Patients

A Study to Assess the Efficacy and Safety of GIA632 Across a Range of Doses in Participants With Moderate to Severe Cutaneous Lichen Planus

Bioenergetic Effects of Aging and Menopause (BEAM)

Discontinuation of Anticoagulations After Successful Catheter Ablation of Atrial Fibrillation

Use of Adult Autologous Stem Cells in Treating People 2 to 3 Weeks After Having a Heart Attack (The Late TIME Study)

Effect of Long-Chain Polyunsaturated Fatty Acid Supplementation on Toddler Cognition

Study of Sorafenib With or Without VT-122 in Patients With Hepatocellular Carcinoma (HCC)

Preoperative BOTOX® Injection for Large Ventral Hernia Repair